MapLight Therapeutics, Inc. (MPLT) vs Sagimet Biosciences Inc. (SGMT)

MapLight Therapeutics, Inc. and Sagimet Biosciences Inc. are both Biotechnology companies. MapLight Therapeutics, Inc. and Sagimet Biosciences Inc. are of similar size ($587.7M and $561.1M). Across the 9 metrics below, Sagimet Biosciences Inc. leads on 6 and MapLight Therapeutics, Inc. on 3.

Valuation

Metric MPLT SGMT Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 1.36 1.92 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (404.49%) (13.85%) (28.84%)
Free cash flow yield (36.85%) (8.50%) (23.03%)

Profitability

Metric MPLT SGMT Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (297.18%) (24.37%) (57.72%)
Return on assets (124.79%) (23.49%) (49.22%)
Return on invested capital (348.44%) (205.24%) 0.00%

Growth

Metric MPLT SGMT Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 82.39% (8.97%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric MPLT SGMT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 16.52 45.02 4.73
Net debt to EBITDA 1.79 1.98 0.96

Dividend

Metric MPLT SGMT Biotechnology median
Dividend yield — — 2.10%
Payout ratio — — 0.00

Size

Metric MPLT SGMT Biotechnology median
Market cap 587.68m 561.10m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack